Advisory: Give yourself extra time when travelling by car to Toronto General Hospital, Princess Margaret Cancer Centre, or Toronto Rehab University Centre. City of Toronto construction on University Ave. may cause delays.
At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Radiation therapy is a highly effective treatment modality for patients with cancer. Used alone, or in combination with other approaches like surgery or chemotherapy, it can cure many patients and control tumours to reduce symptoms and improve quality of life.
We provide consultations for patients with all types of cancer, recommend treatment approaches, deliver safe and effective radiation treatments and offer ongoing follow-up care.
Our team is organized into cancer Site Groups that have developed treatment protocols based on research evidence. These protocols guide decisions on the role, indications and benefits of radiation therapy in specific, individual circumstances.
The Princess Margaret Breast Site Group treats common, rare, and complex forms of breast cancer. Our award-winning
QuickStart Program offers one-day radiotherapy for early-stage breast cancer. We offer personalized, state-of-the-art radiation treatment, including:
Learn more about the inter-professional Breast Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret's Central Nervous System Tumour Program treats common and rare tumours of the central nervous system. Our service is divided into four specific clinical programs which encompass all primary and secondary brain and spinal cord tumours. Each program offers a multidisciplinary conference of cases referred for potential treatment.
Learn more about the inter-professional Central Nervous System Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
Para-Spinal SBRT Physicians
The Princess Margaret’s Ocular Oncology Program provides comprehensive care to patients with cancers of the eyes, orbits and adjacent tissues (conjunctiva, lacrimal glands, eyelids). We treat most cases of choroidal melanoma in Canada, and have helped establish programs in Vancouver, Edmonton and Montreal to help patients receive treatment closer to home. We offer state-of-the-art radiotherapy for ocular oncology, including:
Learn more about the inter-professional Ocular Oncology Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Endocrine Site Group treats common, rare and complex cancers of the thyroid, parathyroid, pituitary gland, pancreas, adrenal glands and neuroendocrine tumours, drawing on cutting-edge technology and treatments. We offer state-of-the-art radiotherapy, including:
We also spearheaded the Ontario clinical trial in the use of Peptide Receptor Radionucleotide Therapy (PRRT) for well differentiated neuroendocrine tumours.
Learn more about the inter-professional Endocrine Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Gastrointestinal Site Group treats all stages and categories of GI cancers, including rare, difficult-to-treat, and advanced-stage malignancy of the upper GI (esophagus and stomach), hepatobiliary cancer (liver, bile duct and pancreas), as well as lower GI (colorectal and anal cancer). We offer state-of-the-art radiation therapy technology, including:
Our program works within the Comprehensive Cancer Center’s multidisciplinary services. Cancer conferences are attended by GI specialists across many disciplines. We discuss challenging and new GI clinical cases to derive consensus for optimal management, providing comprehensive care tailored to each patient’s needs. We also offer many clinical trials, ranging from early to late phase, aiming to improve patient outcomes with fewer side effects.
Learn more about the inter-professional Gastrointestinal Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Genitourinary Site Group treats common, rare and complex forms of cancer affecting the bladder, kidney, urethra, ureters, prostate and testes.
Learn more about the inter-professional Genitourinary Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Gynecologic Site Group treats common, rare and complex forms of cervical, endometrial, ovarian, peritoneal, tubal, vaginal and vulvar cancer.
The Magnetic Resonance guided Radiation Therapy (MRgRT) suite at the Princess Margaret Cancer Centre is the first of its kind in Canada. We offer state-of-the-art, high-precision external radiation and brachytherapy treatment, including:
Learn more about the inter-professional Gynecologic Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Head and Neck Centre treats common, rare and complex forms of cancer of the lips and mouth, oropharynx, hypopharynx, larynx, nasal cavity and sinus, nasopharynx, salivary glands and thyroid.
Learn more about the inter-professional Head & Neck Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Lung Site Group treats common, rare and complex forms of lung cancer.
Learn more about the inter-professional Lung Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Lymphoma and Myeloma Site Group treats lymphoproliferative disorders, including non-Hodgkin’s and Hodgkin’s lymphoma, acute and chronic leukemias, multiple myeloma and related plasma cell disease. We also perform specialized bone marrow stem cell transplants (autologous and allogeneic). New innovative treatments such as chimeric antigen receptor (CAR) T-cell therapy, and promising drugs in clinical trials research are also offered. We work closely with the Lymphoma, Myeloma, Leukemia and Stem cell transplant services to offer state-of-the-art precision radiotherapy and total body irradiation therapy. Clinical and technical innovations include:
Learn more about the inter-professional Lymphoma & Myeloma Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Princess Margaret Melanoma and Skin Site Group treats common, rare and complex forms of melanoma and skin cancer.
Learn more about the inter-professional Melanoma & Skin Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.
The Palliative Radiotherapy and Oligometastasis Program (PROP) now offers both rapid turnaround palliative radiotherapy for patients with a wide array of cancer-related symptoms as well as comprehensive evaluation for indications of ablative radiotherapy intended to eradicate individual metastatic lesions.
For patients needing rapid palliative radiation treatment (tumour-related bleeding, obstruction, pain, cord compression), the program aims to see and initiate treatment for patients within 24-48 hours of referral, more quickly if necessary.
The treatment paradigm for patients with limited sites of metastatic cancer (termed oligometastasis) is shifting in the current era of improved, novel systemic therapy and advancement in radiotherapy technology. As such, PROP will also evaluate patients with oligometastatic and other metastatic cancer amenable to very focused, high-dose radiotherapy intended to eradicate individual metastatic lesions. The technique is termed stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR). It is a highly conformal radiation treatment capable of delivering a higher dose of radiation to the tumor target while sparing the surrounding organs.
Patients can be referred by contacting the lead physician or the team coordinator. After-hours referrals can be readily obtained by contacting the radiation oncologist on call through the Princess Margaret switchboard at 416 946 2000.
The Princess Margaret/Mount Sinai/University of Toronto multidisciplinary sarcoma clinic provides clinical care of soft-tissue and bone sarcomas with specific expertise in thoracic, head and neck, gynecologic oncology and neuro and spine surgery to provide the most comprehensive management for every clinical case. We are committed to research, and have a portfolio of clinical trials investigating:
Learn more about the inter-professional Sarcoma Site Group and its specialized, innovative programs to assess, plan and treat cancer at all stages.